Elsevier

Psychiatry Research

Volume 158, Issue 2, 15 March 2008, Pages 195-205
Psychiatry Research

Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin

https://doi.org/10.1016/j.psychres.2006.09.007Get rights and content

Abstract

Deficit schizophrenia is a relatively homogeneous subtype of patients which is considered helpful to explore the pathogenesis of schizophrenia. The aim of the present study was to reexamine the clinical characteristics of deficit (n = 30) and nondeficit schizophrenia (n = 93) in a Chinese sample and investigate the differences of neurocognitive function among the two subtypes of schizophrenia and the normal controls (n = 103). Schizophrenia patients completed the Brief Psychiatric Rating Scale (BPRS), Scale for the Assessment of Negative Symptoms (SANS) and Scale for the Assessment of Positive Symptoms (SAPS). Additionally, all participants completed an abbreviated version of the Wechsler Adult Intelligence Scale (WAIS-RC) and a neuropsychological test battery examining the executive functions, visuospatial abilities and explicit memory related to the frontal, parietal, and temporal lobe functions. The deficit group received higher scores than the nondeficit group on the BPRS anergia factor and SANS affective flattening, alogia, avolition-apathy, anhedonia-asociality subscales, but not on the SAPS. Both two schizophrenia subgroups performed more poorly on the WAIS-RC and neuropsychological tests than the normal controls. Moreover, deficit patients performed worse than nondeficit patients on the prorated IQ, the Trail Making Test, Wisconsin Card Sorting test and Block Design test. The present study replicated symptom profiles in deficit vs. nondeficit schizophrenia in the Chinese sample. Furthermore, this study suggested that deficit schizophrenia is associated with frontal and parietal lobe impairment, and that temporal lobe dysfunction may be a common basis for cognitive impairment in schizophrenia as a whole.

Introduction

Schizophrenia is characterized by marked clinical variance among patients in their symptoms, biological correlates, disease impact on function, and response to treatment. Present research has been hindered by extreme heterogeneity among patients (Maj, 1998, Tsuang et al., 2000). As a result, researchers have systematically parsed the symptomatology of schizophrenia into more homogeneous diagnostic categories, such as paranoid and non-paranoid subtypes or positive and negative subtypes. Deficit schizophrenia, proposed by Carpenter and colleagues (1988), is defined as a putative schizophrenia subtype, in which the primary negative symptoms are enduring, trait-like features throughout periods of clinical stability. Further, the primary negative symptoms are not attributable to depression, anxiety, paranoia, or medication side effects. The validity of the deficit/nondeficit schizophrenia classification has been supported by many studies indicating marked differences regarding (1) clinical signs and symptoms, (2) course of illness, (3) etiological vulnerability factors, (4) biological correlates, and (5) treatment response (Kirkpatrick et al., 2001). Longitudinal studies have demonstrated that the deficit subtype is a highly stable form of schizophrenia (Amador et al., 1999, Tek et al., 2001). Moreover, comparative studies have shown that the deficit subtype differs from the traditionally defined negative subtype in concept, treatment response and underlying neuropsychological correlates (Kirkpatrick et al., 1989, Kirkpatrick et al., 1993, Kopelowicz et al., 1997, Kopelowicz et al., 2000, Buchanan et al., 1998, Cohen and Docherty, 2004). Therefore, with respect to the exploration of the etiology and pathogenesis of schizophrenia, the implications of the deficit/nondeficit categorization are profound.

With regard to the clinical symptomatology, past studies from a number of countries consistently indicate that deficit patients have more severe anhedonia, less severe depression and anxiety, less suicidal ideation, less severe delusions and suspiciousness, and less substance abuse than nondeficit patients (Kirkpatrick and Buchanan, 1990, Kirkpatrick et al., 1996a, Kirkpatrick et al., 1996b, Earnst and Kring, 1999, Subotnik et al., 2000, Tiryaki et al., 2003, Galderisi et al., 2002, Arango et al., 2004). Furthermore, deficit schizophrenia has been shown to be characterized by poor premorbid functioning coupled with poor social and occupational functioning and quality of life after the onset (Fenton and McGlashan, 1994, Kirkpatrick et al., 1996a, Kirkpatrick et al., 1996b, Tek et al., 2001). Studies in the literature support the validity of the deficit/nondeficit categorization and, moreover, facilitate the identification of a subgroup of patients who appear to exhibit consistent clinical characteristics across independent studies.

In addition to the differences in symptomatology, individuals with deficit schizophrenia exhibit more severe neurological impairments and subsequently greater neurocognitive impairment, which likely contribute to their poorer social functioning (Kirkpatrick et al., 2001). Additionally, neuropsychological studies indicate that deficit schizophrenia patients show a significantly different profile from nondeficit patients when examining the dysfunction of separate brain regions. More specifically, several studies have shown that deficit patients performed significantly worse than nondeficit patients on executive function measures related to frontal lobe functioning (Putnam and Harvey, 2000, Bryson et al., 2001, Galderisi et al., 2002). Further, studies have found abnormalities among deficit schizophrenia patients in the sequencing of complex motor acts, visual attention/information processing tasks, and antisaccadic and eye tracking tasks, all of which are thought to derive from dysfunction in parietal and prefrontal areas (Thaker et al., 1989, Malaspina et al., 1994, Malaspina et al., 2002, Ross, 2000, Ross et al., 1996, Ross et al., 1997, Buchanan et al., 1997, Nkam et al., 2001). In contrast, when comparing the functioning of the temporal lobe between the two subgroups, most of above studies failed to find a significant difference.

To further verify the validity of the deficit/nondeficit categorization and better understand the differences between the two subtypes of schizophrenia, studies examining different geographical and racial samples should be conducted. In our previous work, we developed the Chinese version of the Schedule for the Deficit Syndrome (SDS, Kirkpatrick et al., 1989), the instrument used to classify deficit and nondeficit schizophrenia, and demonstrated that it had good reliability and validity (Wang et al., 2005). Therefore, it is valuable to compare Eastern and Western patients in their symptom profiles and brain functioning impairments on the basis of our reliability and validity research on the SDS-C. To date, there is a paucity of research examining the pathogenesis of deficit and nondeficit schizophrenia in mainland China. Thus, we attempt to use a convergence-of-evidence approach to investigate the symptoms and the underlying biological correlates of the deficit syndrome, including multiple measures such as psychopathological evaluation, neuropsychological assessments, neuroelectrophysiological assessment, and functional neuroanatomical imaging.

In the present study, we first examined the clinical characteristics and psychopathology of deficit and nondeficit schizophrenia in a Chinese sample. We hypothesized that the psychopathological characteristics of Chinese patients with the deficit syndrome would be consistent with the pattern that has emerged from past studies conducted in Western countries. Second, we compared the performances on the neuropsychological measures among the deficit, nondeficit and normal groups. We hypothesized that deficit patients would perform worse on the general ability measure and show a different cognitive function profile from the nondeficit sample, although both subgroups would show a poorer performance than the normal group. In particular, we hypothesized that neuropsychological indices of executive function and visuospatial abilities, which are related to frontal and parietal lobe functioning, would be more impaired in deficit schizophrenia than in nondeficit schizophrenia. However, the indices sensitive to temporal lobe dysfunction, such as the verbal and visual explicit memory measures, would be expected to show no significant differences between the two subtypes of schizophrenia.

Section snippets

Participants

Participants in the current study included 123 individuals diagnosed with schizophrenia who were recruited through the inpatient rehabilitation units of the Changsha Mental Rehabilitation Hospital and 103 healthy controls who were recruited from the local community. Although 129 schizophrenia patients were recruited, only those who completed all the study procedures were included in the data analysis of the current study. The final group consisted of 123 patients. All schizophrenia patients

Demographic characteristics

In the present study, 30 participants (24.4%) met the criteria for deficit syndrome schizophrenia, while 93 participants (75.6%) were classified as nondeficit. Demographic information of the sample and clinical characteristics for the deficit and nondeficit groups are presented in Table 1. There are no significant differences among the three groups with respect to age, education, or gender distribution. However, the three groups differed significantly in marital status (χ2 = 22.82, P < 0.001), with

Discussion

To date, the present study is the first to utilize Carpenter's categorization (Carpenter et al., 1988) of deficit schizophrenia in a Chinese sample to examine the differences in clinical symptoms and neuropsychological functions between deficit and nondeficit schizophrenia. Our results are consistent with findings in past studies regarding the psychopathological characteristics of deficit and nondeficit patients (Buchanan et al., 1990, Fenton and McGlashan, 1994, Kirkpatrick et al., 1996c, Roy

Acknowledgment

The authors thank Dr. Robert W. Buchanan for helping with the design of the study. Additionally, we thank Professor Lin Xu and Randy Patrick Auerbach for their suggestions and proofreading of an earlier version of the manuscript.

References (81)

  • B. Kirkpatrick et al.

    The Schedule for the Deficit syndrome: an instrument for research in schizophrenia

    Psychiatry Research

    (1989)
  • B. Kirkpatrick et al.

    Case identification and stability of the deficit syndrome of schizophrenia

    Psychiatry Research

    (1993)
  • B. Kirkpatrick et al.

    The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse

    Schizophrenia Research

    (1996)
  • B. Kirkpatrick et al.

    The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs

    Schizophrenia Research

    (1996)
  • B. Kirkpatrick et al.

    The deficit syndrome in the Suffolk County Mental Health Project

    Schizophrenia Research

    (1996)
  • D. Malaspina et al.

    Odor identification, eye tracking and deficit syndrome schizophrenia

    Biological Psychiatry

    (2002)
  • I. Nkam et al.

    Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia

    Schizophrenia Research

    (2001)
  • M. Quarantelli et al.

    Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia

    NeuroImage

    (2002)
  • D.E. Ross et al.

    Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome

    Biological Psychiatry

    (1997)
  • R.A. Seckinger et al.

    Olfactory identification and WAIS-R performance in deficit and nondeficit schizophrenia

    Schizophrenia Research

    (2004)
  • K.L. Subotnik et al.

    MMPI discriminators of deficit vs. non-deficit recent-onset schizophrenia patients

    Psychiatry Research

    (2000)
  • C. Tek et al.

    A five-year follow-up study of deficit and nondeficit schizophrenia

    Schizophrenia Research

    (2001)
  • B.I. Turetsky et al.

    P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology

    Biological Psychiatry

    (1998)
  • H.W. Yoon et al.

    An fMRI study of Chinese character reading and picture naming by native Korean speakers

    Neuroscience Letters

    (2006)
  • X.F. Amador et al.

    Stability of the diagnosis of deficit syndrome in schizophrenia

    American Journal of Psychiatry

    (1999)
  • American Psychiatric Association

    Diagnostic and Statistical Manual of Mental Disorders

    (1994)
  • N.C. Andreasen

    Scale for the Assessment of Negative Symptoms. (SANS)

    (1983)
  • N.C. Andreasen

    Scale for the Assessment of Positive Symptoms. (SAPS)

    (1984)
  • A.L. Benton et al.

    Visual perception of line direction in patients with unilateral disease

    Neurology

    (1975)
  • A.L. Benton et al.

    Judgment of line orientation

  • R.W. Buchanan et al.

    Clinical correlates of the deficit syndrome of schizophrenia

    American Journal of Psychiatry

    (1990)
  • R.W. Buchanan et al.

    Neuropsychological impairments in deficit vs. nondeficit forms of schizophrenia

    Archives of General Psychiatry

    (1994)
  • R.W. Buchanan et al.

    Attentional impairments in deficit and nondeficit forms of schizophrenia

    American Journal of Psychiatry

    (1997)
  • R.W. Buchanan et al.

    Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome

    American Journal of Psychiatry

    (1998)
  • W.T. Carpenter et al.

    Deficit and nondeficit forms of schizophrenia: the concept

    American Journal of Psychiatry

    (1988)
  • W.T. Carpenter et al.

    Frontal and parietal blood flow activation during an auditory task differentiate schizophrenic patients with and without primary negative symptoms

    Abstracts - Society for Neuroscience

    (1996)
  • J. Cohen

    Statistical Power Analysis for the Behavioral Sciences

    (1988)
  • A.S. Cohen et al.

    Deficit versus negative syndrome in schizophrenia: prediction of attentional impairment

    Schizophrenia Bulletin

    (2004)
  • A.S. David et al.

    IQ and risk for schizophrenia: a population-based cohort study

    Psychological Medicine

    (1997)
  • P. Delamillieure et al.

    Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report

    American Journal of Psychiatry

    (2000)
  • Cited by (58)

    • Aberrant large-scale brain modules in deficit and non-deficit schizophrenia

      2022, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Patients with severe comorbidity, mental retardation, neurological disorders, alcoholism or substance abuse disorder, head trauma, or previous exposure to electroconvulsive therapy were excluded. We further distinguished DS patients from NDS patients based on the Chinese version of the Schedule for the Deficit Syndrome (SDS) (Kirkpatrick et al., 1989; Wang et al., 2008). Deficit syndromes were labeled as present if patients demonstrated two of the following negative symptoms: diminished emotional expression, restricted affect, poverty of speech, reduced interests, diminished social drive, and diminished sense of purpose.

    • Serum BDNF levels, glycolipid metabolism in deficit schizophrenia: A case-control study

      2022, Asian Journal of Psychiatry
      Citation Excerpt :

      There are several major differences between DS and non-deficit SZ (NDS) patients, including pathophysiological mechanisms, treatment response, biological correlates, and epidemiological risk factors (Kirkpatrick et al., 2017). Compared with NDS patients, DS patients exhibit more severe anhedonia and anergia (Wang et al., 2008), have a poorer prognosis, and deteriorate long-term functioning (Strauss et al., 2010). In addition, DS patients show worsening cognitive impairment (Bora et al., 2017; Kanchanatawan et al., 2018; López-Díaz et al., 2020; Matsumoto et al., 2021; Zhou et al., 2019), distinct reduction in the volumes of white matter and temporal gray (Chee et al., 2020; Tan et al., 2020; Yu et al., 2017), and more extensive cortical thinning in the bilateral inferior frontal gyrus and left superior temporal gyrus (Xie et al., 2019).

    View all citing articles on Scopus
    View full text